|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| C07K 14/705 | |||
| C07K 14/71 | |||
| C07K 16/40 |
| (11) | Number of the document | 2744827 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12753873.4 |
| Date of filing the European patent application | 2012-08-16 | |
| (97) | Date of publication of the European application | 2014-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/051038 |
| Date | 2012-08-16 |
| (87) | Number | WO 2013/028442 |
| Date | 2013-02-28 |
| (30) | Number | Date | Country code |
| 201161525308 P | 2011-08-19 | US | |
| 201261587213 P | 2012-01-17 | US | |
| 201261674405 P | 2012-07-23 | US |
| (72) |
THURSTON, Gavin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-TIE2 ANTIBODIES USES THEREOF |
| ANTI-TIE2 ANTIBODIES USES THEREOF |